AKAN
Price
$1.35
Change
-$0.02 (-1.46%)
Updated
Dec 18, 04:59 PM (EDT)
ALVO
Price
$11.98
Change
-$0.13 (-1.07%)
Updated
Dec 18, 04:59 PM (EDT)
70 days until earnings call
Ad is loading...

AKAN vs ALVO

Header iconAKAN vs ALVO Comparison
Open Charts AKAN vs ALVOBanner chart's image
Akanda
Price$1.35
Change-$0.02 (-1.46%)
Volume$160
CapitalizationN/A
Alvotech
Price$11.98
Change-$0.13 (-1.07%)
Volume$6.58K
CapitalizationN/A
AKAN vs ALVO Comparison Chart
Loading...
AKAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKAN vs. ALVO commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKAN is a Hold and ALVO is a StrongBuy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (AKAN: $1.37 vs. ALVO: $12.11)
Brand notoriety: AKAN and ALVO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AKAN: 13% vs. ALVO: 159%
Market capitalization -- AKAN: $1.25M vs. ALVO: $3.48B
AKAN [@Pharmaceuticals: Other] is valued at $1.25M. ALVO’s [@Pharmaceuticals: Other] market capitalization is $3.48B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKAN’s FA Score shows that 0 FA rating(s) are green whileALVO’s FA Score has 1 green FA rating(s).

  • AKAN’s FA Score: 0 green, 5 red.
  • ALVO’s FA Score: 1 green, 4 red.
According to our system of comparison, ALVO is a better buy in the long-term than AKAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKAN’s TA Score shows that 3 TA indicator(s) are bullish while ALVO’s TA Score has 4 bullish TA indicator(s).

  • AKAN’s TA Score: 3 bullish, 6 bearish.
  • ALVO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALVO is a better buy in the short-term than AKAN.

Price Growth

AKAN (@Pharmaceuticals: Other) experienced а -13.29% price change this week, while ALVO (@Pharmaceuticals: Other) price change was +5.40% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.61%. For the same industry, the average monthly price growth was +1.68%, and the average quarterly price growth was -9.09%.

Reported Earning Dates

AKAN is expected to report earnings on May 02, 2022.

ALVO is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.61% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALVO($3.48B) has a higher market cap than AKAN($1.25M). ALVO YTD gains are higher at: 5.488 vs. AKAN (-96.112). AKAN has higher annual earnings (EBITDA): -3.86M vs. ALVO (-493.67M). ALVO has more cash in the bank: 11.2M vs. AKAN (3.93M). AKAN has less debt than ALVO: AKAN (3.83M) vs ALVO (1.08B). ALVO has higher revenues than AKAN: ALVO (91.4M) vs AKAN (111K).
AKANALVOAKAN / ALVO
Capitalization1.25M3.48B0%
EBITDA-3.86M-493.67M1%
Gain YTD-96.1125.488-1,751%
P/E RatioN/A57.47-
Revenue111K91.4M0%
Total Cash3.93M11.2M35%
Total Debt3.83M1.08B0%
TECHNICAL ANALYSIS
Technical Analysis
AKANALVO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
49%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
46%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
42%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
53%
Advances
ODDS (%)
Bullish Trend 10 days ago
86%
Bullish Trend 2 days ago
64%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 10 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
51%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
View a ticker or compare two or three
Ad is loading...
AKAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCEUX17.74-0.06
-0.34%
Franklin U.S. Core Equity Advisor
BRTNX76.04-0.51
-0.67%
Bretton Fund
JDWAX113.43-0.82
-0.72%
Janus Henderson Global Research A
VSCPX347.35-3.96
-1.13%
Vanguard Small Cap Index InstlPlus
LSCNX25.51-0.32
-1.24%
Loomis Sayles Small Cap Value N

AKAN and

Correlation & Price change

A.I.dvisor tells us that AKAN and ACB have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKAN and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKAN
1D Price
Change %
AKAN100%
+1.48%
ACB - AKAN
27%
Poorly correlated
+4.20%
SNOA - AKAN
25%
Poorly correlated
-2.26%
OGI - AKAN
25%
Poorly correlated
+5.23%
SNDL - AKAN
24%
Poorly correlated
+4.17%
TLRY - AKAN
23%
Poorly correlated
+3.33%
More

ALVO and

Correlation & Price change

A.I.dvisor tells us that ALVO and CTLT have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and CTLT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
+0.50%
CTLT - ALVO
28%
Poorly correlated
N/A
AKAN - ALVO
22%
Poorly correlated
+1.48%
CURLF - ALVO
21%
Poorly correlated
+9.46%
CRON - ALVO
20%
Poorly correlated
+1.04%
ELAN - ALVO
20%
Poorly correlated
+1.40%
More